Fecal transplant via retention enema for refractory or recurrent clostridium difficile infection

Archives of Internal Medicine

Volumn 172, Issue 2, 2012, Pages 191-193

  Kassam, Zain ^a   Hundal, Rajveer ^a   Marshall, John K ^a,b   Lee, Christine H ^a,c  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENEMA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN; METRONIDAZOLE; RETENTION ENEMA; UNCLASSIFIED DRUG; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMBINATION CHEMOTHERAPY; DIARRHEA; DISEASE DURATION; DRUG TREATMENT FAILURE; ENZYME IMMUNOASSAY; EXPERIMENTAL THERAPY; FECAL TRANSPLANT; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; MONOTHERAPY; PRIORITY JOURNAL; RECURRENT INFECTION; SCREENING TEST; SYPHILIS SEROLOGY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; DIARRHEA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENEMA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; RECURRENCE;

EID: 84862908065     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.172.2.191     Document Type: Article

References (9)

1. Kelly CP, LaMont JT. Clostridium difficile - more difficult than ever. N Engl J Med. 2008;359(18):1932-1940.
2. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med. 2005;353(23):2442-2449. (Pubitemid 41770165)
3. Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009; 30(1):57-66.
4. Pépin J, Saheb N, Coulombe MA, et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005;41(9):1254-1260. (Pubitemid 41532667)
5. MacConnachie AA, Fox R, Kennedy DR, Seaton RA. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM. 2009; 102(11):781-784.
6. Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol. 2010;44(8):567-570.
7. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003;36(5):580-585. (Pubitemid 36259562)
8. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol. 2004;38(6):475-483. (Pubitemid 38808419)
9. Lüning TH, Keemers-Gels ME, Barendregt WB, Tan AC, Rosman C. Colonoscopic perforations: a review of 30,366 patients. Surg Endosc. 2007;21(6): 994-997. (Pubitemid 47055793)